Pentavere Research Group Inc. is a Toronto-based AI digital health company and a subsidiary of HEALWELL AI. It is recognized for developing innovative AI solutions that help identify eligible patients for approved medications and interventions. The company excels in data structuring and abstraction, which is essential for enhancing clinical value and meeting the needs of patients and healthcare providers.
One of Pentavere’s key offerings is its AI engine for patient identification, designed to ensure that the right treatments reach the right patients at the right time. The DARWEN™ AI system is another significant product, used in research collaborations to detect radiation-related toxicities in cancer patients through electronic health records. Pentavere has received accolades for its contributions to healthcare accessibility and personalization, including the Prix Galien USA 2024 award for Best Startup in Digital Health & Medical Technology.
Through its partnerships with major hospital networks and its integration with HEALWELL AI, Pentavere continues to expand its impact in the pharmaceutical and life sciences sectors.